Medical Devices Startups

ASG Eye Hospital is a network of eye hospitals in India providing comprehensive ophthalmic care across subspecialties, backed by diagnostic and surgical infrastructure. It also runs fellowship and surgical training programs and partners with public health bodies and state governments, including a collaboration with the Government of Bihar to set up over 200 vision centres.

2 investors

Astral Systems develops fusion technology to produce medical isotopes and power decentralised energy solutions for healthcare providers and researchers.

2 investors

bioMérieux develops in vitro diagnostic systems and molecular testing panels for pathogen detection in clinical, food safety, and pharmaceutical quality control settings. The company serves healthcare providers, laboratories, food industry, and pharmaceutical manufacturers with rapid PCR-based diagnostic solutions.

2 investors

Caldera Medical develops medical devices for women's pelvic health, including treatments for stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue removal. The company provides its products along with physician training and support for treating patients.

2 investors

Atom develops AI-powered artificial limbs, starting with a prosthetic called Atom Touch, aimed at restoring physical ability for people who have lost limbs. The company operates in the medical device and prosthetics space, combining artificial intelligence with the human body.

2 investors

Atomo Diagnostics develops proprietary rapid diagnostic test platforms and devices designed for point-of-care and self-testing applications. The company licenses its user-centered diagnostic platforms to medical device companies for creating innovative rapid tests across various health conditions.

2 investors

Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.

2 investors

Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.

2 investors

Attivare develops AI-powered personalized immunotherapy treatments using a proprietary biomaterial scaffold (ATTImmune) that delivers immune agonists directly to tumor microenvironments, aiming to reduce systemic toxicity in cancer and infectious disease treatment.

2 investors

Aurie designs a reusable intermittent catheter system intended to reduce infection risk and improve ease of use compared with single-use catheters. The company develops catheter and ostomy products in partnership with the disabled community to support health, independence, and daily living.

2 investors

The page profiles a scientific advisor in surgical endoscopy and flexible robotics, indicating the company operates in medical technology related to interventional endoscopy and minimally invasive surgery. It provides no direct description of the company's own products or offerings.

2 investors

AUSTRAL Dx develops AI-powered ultrasound technology for the medtech industry, combining expertise in artificial intelligence and ultrasound imaging with capabilities in product development, regulatory approval, and market commercialization.

2 investors

Avatar Medical builds software that converts medical images into interactive 3D "avatars" to help patients understand their conditions and support surgeons in planning procedures. Its products are used by hospitals and clinicians across multiple medical specialties for patient consultation, surgical planning, and medical education.

2 investors

Avelo develops diagnostic technology aimed at closing the diagnostic gap in respiratory disease, so patients receive timely and accurate information for effective treatment. The company operates in the medical diagnostics field with an emphasis on technology and science.

2 investors

Avionova develops bioastronautics research and technology commercialization solutions, serving the aerospace and medical sectors with expertise in dual-use product strategy and commercialization.

2 investors

AVS develops Pulse IVL, an intravascular lithotripsy system that uses high-frequency pulsatile pressure waves generated from pressurized CO2 to fracture arterial calcium and restore blood flow. The system is being clinically evaluated as a treatment for severe calcified arterial disease, including peripheral, coronary, and carotid applications, for use by physicians treating vascular patients.

2 investors

Axena Health develops the Leva Pelvic Health System, a clinically tested, non-invasive treatment for pelvic health conditions such as incontinence. The company focuses on women's health and offers its system to patients including female veterans through federal healthcare providers.

2 investors

Axial3D provides automated segmentation and 3D surgical planning solutions for medical device companies and hospitals to enable patient-specific surgical care. The platform uses AI and data-driven technology to support personalized surgical planning and device development in orthopedics and other surgical specialties.

2 investors

Axinesis develops neurorehabilitation devices that deliver intensive, gamified functional therapy for patients with motor and cognitive disorders, including stroke and cerebral palsy. The devices provide self-adaptive upper-extremity rehabilitation for care centers and patients across the recovery pathway.

2 investors

Axomove is a digital clinic providing personalized physiotherapy and musculoskeletal rehabilitation programs, offering a catalog of over 2,300 validated exercise videos plus remote medical monitoring (télésurveillance). It serves healthcare facilities, employers, insurers, and physiotherapists in France, including a CE-marked medical device reimbursed for remote monitoring of chronic lower back pain.

2 investors

Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.

2 investors

AZmed develops AI software for medical imaging that assists radiologists in analyzing X-rays, with a focus on fracture detection. The company serves hospitals and imaging centers across multiple countries.

2 investors

Bambusa Therapeutics develops bispecific antibodies for immunological and inflammatory (I&I) disorders, using antibody engineering to target multiple I&I indications. The clinical-stage biotech company serves patients across a range of I&I diseases.

2 investors

BBy manufactures a device that converts breast milk into shelf-stable powder while preserving its immunological properties, serving neonatal intensive care units seeking to reduce preparation time and milk waste.

2 investors